跳至主要内容
临床试验/IRCT2017091910222N12
IRCT2017091910222N12招募中3 期

Evaluation the effect of oral capsule of Peganum harmalaseed on bone density in menopausal womenprone to osteoporosis

Vice chancellor for research of Shahrekord University of Medical Science0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 years 至 65 years(—)
性别
Female

入选标准

  • Inclusion Criteria: Postmenopausal women who at least 12 month past after amenorrhea without correlation with pregnancy, breast-feeding or other hormonal disorders ;prone to osreoprosis with T score of less than 2.5 in bone density measurement.
  • Exclusion criteria: Gastrointestinal absorption disorder; Thyroid patients; Kidney and liver diseases

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research of Shahrekord University of Medical Science

相似试验